239 related articles for article (PubMed ID: 33750896)
21. Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A.
Sancho S; Young P; Suter U
Brain; 2001 Nov; 124(Pt 11):2177-87. PubMed ID: 11673320
[TBL] [Abstract][Full Text] [Related]
22. An essential role of MAG in mediating axon-myelin attachment in Charcot-Marie-Tooth 1A disease.
Kinter J; Lazzati T; Schmid D; Zeis T; Erne B; Lützelschwab R; Steck AJ; Pareyson D; Peles E; Schaeren-Wiemers N
Neurobiol Dis; 2013 Jan; 49():221-31. PubMed ID: 22940629
[TBL] [Abstract][Full Text] [Related]
23. Varying survival of motoneurons and activation of distinct molecular mechanism in response to altered peripheral myelin protein 22 gene dosage.
Nattkämper H; Halfter H; Khazaei MR; Lohmann T; Gess B; Eisenacher M; Willscher E; Young P
J Neurochem; 2009 Aug; 110(3):935-46. PubMed ID: 19493167
[TBL] [Abstract][Full Text] [Related]
24. Biochemical characterization of protein quality control mechanisms during disease progression in the C22 mouse model of CMT1A.
Chittoor VG; Sooyeon L; Rangaraju S; Nicks JR; Schmidt JT; Madorsky I; Narvaez DC; Notterpek L
ASN Neuro; 2013 Dec; 5(5):e00128. PubMed ID: 24175617
[TBL] [Abstract][Full Text] [Related]
25. Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A).
Prukop T; Stenzel J; Wernick S; Kungl T; Mroczek M; Adam J; Ewers D; Nabirotchkin S; Nave KA; Hajj R; Cohen D; Sereda MW
PLoS One; 2019; 14(1):e0209752. PubMed ID: 30650121
[TBL] [Abstract][Full Text] [Related]
26. A novel case of concurrent occurrence of demyelinating-polyneuropathy-causing PMP22 duplication and SOX10 gene mutation producing severe hypertrophic neuropathy.
Matsuda N; Ootsuki K; Kobayashi S; Nemoto A; Kubo H; Usami SI; Kanani K
BMC Neurol; 2021 Jun; 21(1):243. PubMed ID: 34171997
[TBL] [Abstract][Full Text] [Related]
27. PMP22 expression in dermal nerve myelin from patients with CMT1A.
Katona I; Wu X; Feely SM; Sottile S; Siskind CE; Miller LJ; Shy ME; Li J
Brain; 2009 Jul; 132(Pt 7):1734-40. PubMed ID: 19447823
[TBL] [Abstract][Full Text] [Related]
28. Peripheral myelin protein 22 gene duplication with atypical presentations: a new example of the wide spectrum of Charcot-Marie-Tooth 1A disease.
Mathis S; Corcia P; Tazir M; Camu W; Magdelaine C; Latour P; Biberon J; Guennoc AM; Richard L; Magy L; Funalot B; Vallat JM
Neuromuscul Disord; 2014 Jun; 24(6):524-8. PubMed ID: 24792522
[TBL] [Abstract][Full Text] [Related]
29. Treating PMP22 gene duplication-related Charcot-Marie-Tooth disease: the past, the present and the future.
Boutary S; Echaniz-Laguna A; Adams D; Loisel-Duwattez J; Schumacher M; Massaad C; Massaad-Massade L
Transl Res; 2021 Jan; 227():100-111. PubMed ID: 32693030
[TBL] [Abstract][Full Text] [Related]
30. Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy.
Nobbio L; Fiorese F; Vigo T; Cilli M; Gherardi G; Grandis M; Melcangi RC; Mancardi G; Abbruzzese M; Schenone A
J Neuropathol Exp Neurol; 2009 May; 68(5):441-55. PubMed ID: 19525893
[TBL] [Abstract][Full Text] [Related]
31. Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy.
Sociali G; Visigalli D; Prukop T; Cervellini I; Mannino E; Venturi C; Bruzzone S; Sereda MW; Schenone A
Neurobiol Dis; 2016 Nov; 95():145-57. PubMed ID: 27431093
[TBL] [Abstract][Full Text] [Related]
32. Myelinated axons fail to develop properly in a genetically authentic mouse model of Charcot-Marie-Tooth disease type 2E.
Lancaster E; Li J; Hanania T; Liem R; Scheideler MA; Scherer SS
Exp Neurol; 2018 Oct; 308():13-25. PubMed ID: 29940160
[TBL] [Abstract][Full Text] [Related]
33. Distal enhancers upstream of the Charcot-Marie-Tooth type 1A disease gene PMP22.
Jones EA; Brewer MH; Srinivasan R; Krueger C; Sun G; Charney KN; Keles S; Antonellis A; Svaren J
Hum Mol Genet; 2012 Apr; 21(7):1581-91. PubMed ID: 22180461
[TBL] [Abstract][Full Text] [Related]
34. Charcot-Marie-Tooth disease and related inherited neuropathies.
Murakami T; Garcia CA; Reiter LT; Lupski JR
Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
[TBL] [Abstract][Full Text] [Related]
35. Synergistic PXT3003 therapy uncouples neuromuscular function from dysmyelination in male Charcot-Marie-Tooth disease type 1A (CMT1A) rats.
Prukop T; Wernick S; Boussicault L; Ewers D; Jäger K; Adam J; Winter L; Quintes S; Linhoff L; Barrantes-Freer A; Bartl M; Czesnik D; Zschüntzsch J; Schmidt J; Primas G; Laffaire J; Rinaudo P; Brureau A; Nabirotchkin S; Schwab MH; Nave KA; Hajj R; Cohen D; Sereda MW
J Neurosci Res; 2020 Oct; 98(10):1933-1952. PubMed ID: 32588471
[TBL] [Abstract][Full Text] [Related]
36. PMP22 antisense oligonucleotides reverse Charcot-Marie-Tooth disease type 1A features in rodent models.
Zhao HT; Damle S; Ikeda-Lee K; Kuntz S; Li J; Mohan A; Kim A; Hung G; Scheideler MA; Scherer SS; Svaren J; Swayze EE; Kordasiewicz HB
J Clin Invest; 2018 Jan; 128(1):359-368. PubMed ID: 29202483
[TBL] [Abstract][Full Text] [Related]
37. Mutational analysis of PMP22, EGR2, LITAF and NEFL in Greek Charcot-Marie-Tooth type 1 patients.
Koutsis G; Pandraud A; Karadima G; Panas M; Reilly MM; Floroskufi P; Wood NW; Houlden H
Clin Genet; 2013 Apr; 83(4):388-91. PubMed ID: 22765307
[No Abstract] [Full Text] [Related]
38. Myelin and axon pathology in a long-term study of PMP22-overexpressing mice.
Verhamme C; King RH; ten Asbroek AL; Muddle JR; Nourallah M; Wolterman R; Baas F; van Schaik IN
J Neuropathol Exp Neurol; 2011 May; 70(5):386-98. PubMed ID: 21487305
[TBL] [Abstract][Full Text] [Related]
39. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves.
Maier M; Berger P; Nave KA; Suter U
Mol Cell Neurosci; 2002 May; 20(1):93-109. PubMed ID: 12056842
[TBL] [Abstract][Full Text] [Related]
40. Gene dosage effects in hereditary peripheral neuropathy. Expression of peripheral myelin protein 22 in Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies nerve biopsies.
Gabriel JM; Erne B; Pareyson D; Sghirlanzoni A; Taroni F; Steck AJ
Neurology; 1997 Dec; 49(6):1635-40. PubMed ID: 9409359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
